(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid

$(3beta,5beta)-3-[(2,6-dideoxy-4-O-beta-D\-glucopyranosyl-beta-D\-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide Struktur$

Bezeichnung:: (3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid

Englisch Name:: (3beta,5beta)-3-[(2,6-dideoxy-4-O-beta-D\-glucopyranosyl-beta-D\-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide

Synonyma:: Erysimosid;- D-glucopyranosyl-âCard-20(22)-enolide,3-[(2,6-dideoxy-4-O-â-D-ribo-hexopyranosyl)- oxy]-5,14-dihydroxy-19-oxo-,(3â3β-[(4-O-β-D-Glucopyranosyl-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5β-card-20(22)-enolide;Card-20(22)-enolide, 3-[(2,6-dideoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-;(3beta,5beta)-3-[(2,6-dideoxy-4-O-beta-D\-glucopyranosyl-beta-D\-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide

Request For Quotation

Eigenschaften Sicherheit Verwendungswort Produktionsfirma 9

(3β,5β)-3-[(2,6-Didesoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolid Eigenschaften

Global( 9)Lieferanten

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Hangzhou MolCore BioPharmatech Co.,Ltd.	+86-057181025280; +8617767106207	sales@molcore.com	China	49734	58
Hu Bei Jiutian Bio-medical Technology CO.,Ltd	027-88013699 17354350817	Ryan@jiutian-bio.com	China	5945	58
Shenzhen Regent Biochemical Technology Co., Ltd.	0755-85201366 18938635012	sales@regentsciences.com	China	9378	58
Hubei Xinyang Medical Technology Co., Ltd	15347293736	2853117764@yongstandards.com	China	9988	58
TCI (Shanghai) Chemical Trading Co., Ltd.	021-61109150	sales@tcisct.com	China	29717	58
Shaanxi Dideu Newmaterial Co., Ltd.	029-63373950 17392216152	1050@dideu.com	China	9998	58
Chengdu Peter-like Biotechnology Co., Ltd.	028-81700200 13308200041	2851167782@qq.com	China	10935	58
Biosynth Biological Technology (Suzhou) Co Ltd	51288865780	sales@biosynth.com	China	6051	58

(3beta,5beta)-3-[(2,6-dideoxy-4-O-beta-D\-glucopyranosyl-beta-D\-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxocard-20(22)-enolide
Erysimosid
3β-[(4-O-β-D-Glucopyranosyl-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-5β-card-20(22)-enolide
Card-20(22)-enolide, 3-[(2,6-dideoxy-4-O-β-D-glucopyranosyl-β-D-ribo-hexopyranosyl)oxy]-5,14-dihydroxy-19-oxo-, (3β,5β)-
- D-glucopyranosyl-â
Card-20(22)-enolide,3-[(2,6-dideoxy-4-O-â
-D-ribo-hexopyranosyl)- oxy]-5,14-dihydroxy-19-oxo-,(3â
7082-34-0
C35H52O14